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Abstract
Background:  17β-hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus (17β-
HSDcl) is a member of the short-chain dehydrogenase/reductase (SDR) superfamily. SDR proteins
usually function as dimers or tetramers and 17β-HSDcl is also a homodimer under native
conditions.
Results: We have investigated here which secondary structure elements are involved in the
dimerization of 17β-HSDcl and examined the importance of dimerization for the enzyme activity.
Sequence similarity with trihydroxynaphthalene reductase from Magnaporthe grisea indicated that
Arg129 and His111 from the αE-helices interact with the Asp121, Glu117 and Asp187 residues
from the αE and αF-helices of the neighbouring subunit. The Arg129Asp and His111Leu mutations
both rendered 17β-HSDcl monomeric, while the mutant 17β-HSDcl-His111Ala was dimeric.
Circular dichroism spectroscopy analysis confirmed the conservation of the secondary structure
in both monomers. The three mutant proteins all bound coenzyme, as shown by fluorescence
quenching in the presence of NADP+, but both monomers showed no enzymatic activity.
Conclusion: We have shown by site-directed mutagenesis and structure/function analysis that
17β-HSDcl dimerization involves the αE and αF helices of both subunits. Neighbouring subunits
are connected through hydrophobic interactions, H-bonds and salt bridges involving amino acid
residues His111 and Arg129. Since the substitutions of these two amino acid residues lead to
inactive monomers with conserved secondary structure, we suggest dimerization is a prerequisite
for catalysis. A detailed understanding of this dimerization could lead to the development of
compounds that will specifically prevent dimerization, thereby serving as a new type of inhibitor.
Background
Members of the short-chain dehydrogenase/reductase
(SDR) superfamily are non-metallo enzymes with molec-
ular masses between 25 and 35 kDa that function in the
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form of dimers or tetramers [1]. The crystal structures of
several SDR proteins have revealed that the protein fold is
highly conserved within this superfamily [2]. The SDR
tetramers display 222 symmetry with two different inter-
faces between their 4 subunits, described by three orthog-
onal molecular axes, called P, Q and R [3]. The most
extensive contacts are those spanning the Q-axis and
involve two helices, αE and αF. In most homodimeric
SDRs for which the structure is known, dimerization also
occurs across this interface. So far, only one SDR protein,
the 3α-hydroxysteroid dehydrogenase/carbonyl reductase
(3α-HSD/CR) from Comamonas testosteroni (pdb code
1FK8), has been shown to differ in its mode of dimeriza-
tion. In this case, dimerization takes place across the P-
axis interface, formed mainly by the αG helices and by
interactions between the βG strands of two neighbouring
subunits [4,5]. To date, only two monomeric structures,
those of porcine testicular carbonyl reductase (PTCR)
(pdb code 1N5D) and human carbonyl reductase (CBR1)
(pdb code 1WMA), are known within the SDR super-
family [6,7].
Although there are about three thousand members of the
SDR superfamily in the species studied [8], 17β-HSD from
the fungus Cochliobolus lunatus (17β-HSDcl) [9] is cur-
rently the only fungal HSD member that has been charac-
terized. The enzyme has been purified, and also cloned
and expressed in E. coli [9,10]. Under native conditions,
both recombinant [10] and natural [9] 17β-HSDcl form
dimers. 17β-HSDcl is homologous to fungal reductases:
to versicolorin reductases from Aspergillus parasiticus and
Emericella nidulans, which are involved in aflatoxin bio-
synthesis; and to the 1,3,8-trihydroxynaphthalene reduct-
ases and 1,3,6,8-tetrahydroxynaphthalene reductases
(3HNR, 4HNR) from Magnaporthe grisea, Ophiostoma floc-
cosum and other fungi, which are involved in melanin bio-
synthesis [11]. 3HNR and 4HNR catalyze an essential
reaction in the biosynthesis of melanin, a virulence factor
of phyto-pathogenic fungi, as well as of fungi pathogenic
to humans [12-15]. These enzymes are the biochemical
targets of several commercially important fungicides that
are used to prevent blast disease in rice plants [15,16]. The
study of the fungal 17β-HSD will, therefore, contribute to
Ribbon diagram showing the dimerization of 17β-HSDcl across the Q-axis Figure 1
Ribbon diagram showing the dimerization of 17β-HSDcl across the Q-axis. The amino acids crucial for the dimeriza-
tion across the Q-axes are depicted. The enlarged subunit interactions at the αE-αE contact region are also shown (inset).BMC Biochemistry 2005, 6:28 http://www.biomedcentral.com/1471-2091/6/28
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a better understanding of the functionality of these
homologous fungal enzymes that are targets for the
design of novel antifungal agents. As fungal 17β-HSD
exhibits about 30% amino acid identity to human 17β-
HSD types 4 and 8 [11], this could also lead to an under-
standing of the mechanisms of catalysis in human HSDs,
which are implicated in the development of steroid-
dependent forms of cancer, polycystic kidney disease, reg-
ulation of blood pressure, Alzheimer's disease and obesity
[17-23]. A detailed understanding of the individual
amino acids that are important for dimerization could
enable the design of compounds that would specifically
prevent dimerization, and consequently the enzyme activ-
ity of the SDR proteins, and should therefore serve as new
types of drugs [24].
Dimerization of the SDR proteins has already been stud-
ied in Drosophila alcohol dehydrogenase (ADH), where
ethyl methanesulphonate-induced null mutants were pre-
pared and examined. Among the mutants studied, the
inactive mutant Ala159Thr did not form a stable
homodimer, suggesting that Ala159 is important for
hydrophobic interactions that stabilize the ADH dimer
[25]. Dimerization has also been studied in human 17β-
HSD type 1, an enzyme that has a high affinity for dimer
formation (dimer dissociation constant Kdd ≤ 5 pM) and
consequently exists only as a dimer in vitro [26]. The 17β-
HSD type 1 mutations Leu111Glu/Val113Phe and
Ala170Glu+Phe172 abolished its activity and changed the
folding of the enzyme. Both mutated proteins formed
aggregates with apparent molecular weights of more than
300 kDa; monomeric or dimeric forms of the enzyme
were not seen [26]. Based on a comparison of the struc-
tures of fungal 17β-HSD [27,28] (Figure 1) and the
homotetrameric 3HNR from Magnaporthe grisea (pdb
code 1YBV) [12], we investigated the dimerization of 17β-
HSDcl by site-directed mutagenesis. We have identified
the secondary structure elements and the amino acids
essential for dimerization and have demonstrated the
relationship between dimerization and enzyme activity.
Results
Structural comparisons indicate that His111 and Arg129 
are involved in dimerization
The sequence alignments and structural comparison of
the three-dimensional models of fungal 17β-HSD [27],
supported by our preliminary crystallographic data [28],
with the homologous 3HNR [pdb code 1YBV], aligned
without gaps between residue number 15 to 222 in 17β-
HSDcl and residues 26 to 233 in 3HNR (60% of identical
amino acids), identified strong hydrophobic and aro-
matic interactions across the Q-axis (Phe120, Phe124,
Phe132, Phe133, Phe177) and potential salt bridges/H-
bonds between the αE and αF helices of the two subunits,
all of which may stabilize dimerization (Table 1, Figure
1). One salt bridge can be formed between Arg129 and
Glu117 and/or Asp121 from the αE helices, while His111,
which is positioned in front of the αE helix, can form an
H-bond with Asp187 from the αF helix (Table 1, Figure
1). The interactions between the P-axis-related subunits
are not so extensive and the surface amino acids are less
hydrophobic than those of tetrameric 3HNR (Table 1). To
test our hypothesis that dimerization takes place across
the Q-axis, the His111Ala, His111Leu and Arg129Asp
mutants were prepared with the aim of selectively omit-
ting one H-bond (His111Ala and His111Leu) and of
introducing electrostatic repulsion between the mono-
mers (Arg129Asp).
The His111Leu and Arg129Asp mutations each result in 
monomeric proteins
The purities of the expressed proteins were checked by
SDS-PAGE, where all of the proteins appeared as bands
with the expected molecular mass of 28 kDa and were
approx. 90% homogenous. The solution molecular mass
was determined by gel filtration and by non-denaturing
Table 1: Comparisons of the amino acids potentially involved in dimerization across the Q- and P-axis interface in 3HNR and 17β-
HSDcl.
Q-axis interface P-axis interface
3HNR 17β-HSDcl 3HNR 17β-HSDcl
hydrophobic interactions hydrophobic interactions
Phe131 Phe120 Phe261 Phe249
Phe135 Phe124 Trp269 Trp257
Phe143 Phe132 salt bridges
Phe144 Phe133 Asp266-Arg52
Phe188 Phe177 Asp278-Lys273 Asp266-Lys26
salt bridges/H-bonds
Arg140-Asp132 Arg129-Asp121/Glu117
His122-Asp198 His111-Asp187BMC Biochemistry 2005, 6:28 http://www.biomedcentral.com/1471-2091/6/28
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PAGE. His111Ala-17β-HSDcl remained a dimer, as with
the wild-type protein, while the other two mutations,
His111Leu and Arg129Asp, resulted in monomers (Figure
2). The dimers eluted at the retention time of albumin
with a molecular weight of 66 kDa, and the monomers
eluted at a time similar to that of carbonic anhydrase (29
kDa) (Figure 2a). Differences in mobility of monomeric
mutants compared to the dimeric proteins was also
observed on the native PAGE (Figure 2b).
Monomer secondary structure is conserved, although the 
proteins differ in their thermal denaturation 
characteristics
The secondary structures of the wild-type and mutant
enzymes were analysed through circular dichroism spec-
troscopy. This method revealed similar conformations for
all the proteins (Figure 3). The thermal denaturation was
measured by following the change of the ellipticity at 222
nm as a function of the temperature. Two behaviours were
recognized, that of the wild-type protein and the
His111Ala mutant, and that of the two monomeric
mutants, His111Leu and Arg129Asp. The melting curves
of the wild-type protein and the His111Ala mutant were
sigmoidal, revealing a cooperative denaturation. The
wild-type protein had a Tm of 44°C, and the His111Ala
mutant, of 37°C. The forms of the melting curves of the
other two mutants suggested lower cooperativities of
denaturation. The melting points were 48°C for the
His111Leu mutant and 50°C for Arg129Asp (Figure 3)






NADP+ (s-1) kcat/KM, NADPH (s-1M-1) kcat/KM, NADP+ (s-1M-1)T m (°C)
Wild type 0.2 6.5 0.06 3.8 0.65 5.8 × 105 1.1 × 107 44
His111Ala 5.8 50.6 4.6 2.4 0.9 4.7 × 104 1.9 × 105 37
His111Leu 19.9 N.A. N.A. N.A. N.A. N.A. N.A. 48
Arg129Asp 12.8 N.A. N.A. N.A. N.A. N.A. N.A. 50
Kinetic constants for the reduction and oxidation of the substrates 4-estrene-3,17-dione and 4-estrene-17β-ol-3-one (100 µM) (Keq = 2.46 ± 0.11 
[38]) that were catalyzed by the wild-type and mutant 17β-HSDcl in the presence of the coenzymes NADPH and NADP+ (100 µM), at pH 8 and 
25°C. The temperature midpoints (Tm) are also given. (* determined by fluorescence titrations; N.A.: no activity detected)
Molecular masses Figure 2
Molecular masses. A) Gel filtration: Native molecular masses were analyzed by gel filtration. The molecular mass standards 
are represented () by a number from 1 to 8, respectively: myoglobin (17.5 kDa), carbonic anhydrase (29 kDa), ovalbumin (44 
kDa), albumin (66 kDa), alcohol dehydrogenase (150 kDa), β-amylase (200 kDa), apoferritin (443 kDa) and thyroglobulin (669 
kDa). The retention time for the dimers (D) and monomers (M) are also indicated (❍ ). B) Native PAGE: Eight µg of the 17β-
HSDcl wild-type and mutant proteins were applied to the gel, which was stained with Coomassie Blue. Bovine serum albumin 
(BSA) was used for comparison.BMC Biochemistry 2005, 6:28 http://www.biomedcentral.com/1471-2091/6/28
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(Table 2).
The coenzyme binds to the monomeric mutants
We measured the formation of the binary complexes of
E•NADP+ for the wild-type and mutant enzymes. The flu-
orescence of all of the proteins was quenched by the addi-
tion of the coenzyme, but the Kd values differed. The Kd
value for the dimeric mutant His111Ala increased 30-
fold, and those for the His111Leu and Arg129Asp mono-
mers increased 100-fold and 60-fold, respectively, when
compared with the wild-type enzyme (Table 2). These
results support the circular dichroism data, suggesting
only minor changes in the coenzyme binding site, even in
the monomeric enzymes.
The His111Leu and Arg129Asp mutants are not active on 
the substrates
The oxidation of 4-estrene-17β-ol-3-one and the reduc-
tion of 4-estrene-3,17-dione by the wild-type and mutant
proteins in the presence of NADP+ and NADPH showed
enzyme activities for the wild-type protein and for the
His111Ala mutant, but no detectable activities for the
monomeric His111Leu and Arg129Asp proteins within a
450 s sweep. Although the His111Ala mutant was active,
Circular dichroism spectra and thermal denaturation Figure 3
Circular dichroism spectra and thermal denaturation. The circular dichroism spectra were recorded by measuring the 
ellipticity as a function of wavelength at 0.1 nm increments between 260 and 197 nm at 20°C. The thermal denaturation was 
determined by measuring the ellipticity as a function of temperature at 0.1°C increments between 4 and 70°C (inset). The pro-
tein concentrations used were approximately 0.2 mg/ml.BMC Biochemistry 2005, 6:28 http://www.biomedcentral.com/1471-2091/6/28
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its kinetic constants differed from those of the wild-type
protein (Table 2). The KM values for both of the coen-
zymes, NADP+  and NADPH, were increased in the
His111Ala mutant (77-fold and 8-fold, respectively),
while the kcat values remained similar (Table 2). The spe-
cificity constants, kcat/Km, for NADP+ and NADPH, were
58-fold and 12-fold lower, respectively, when compared
to those for the wild-type enzyme (Table 2).
Since we could not detect any enzyme activities with the
monomeric mutants within the 450 s sweep, we also
tested the enzyme activities by TLC analysis of the prod-
ucts after 24-h incubations of the proteins with 4-estrene-
17β-ol-3-one and NADP+. Again, the wild-type and
His111Ala mutant proteins converted this substrate to
equilibrium concentrations, while the His111Leu and
Arg129Asp mutant proteins did not (data not shown).
Discussion
The dimerization of fungal 17β-HSD occurs across the Q-
axis
Among the tens of SDR enzymes for which the three-
dimensional structures have been resolved, only two are
known to be active in solution as monomers (pdb code
1N5D and 1WMA) [6,7]. We have shown previously, that
the wild-type 17β-HSDcl acts as dimer [10]. In order to
influence the formation of this dimer, we substituted two
surface amino acids which should not, per se, prevent
either the folding or the activity. To avoid possible coop-
erative phenomena, we prepared mutants with single sub-
stitutions, yet we knew that in the dimer the effects would
be doubled.
Inspection of the three-dimensional structural model of
17β-HSDcl [27] supported by our preliminary crystallo-
graphic data [28] revealed that His111 from each subunit
could form an H-bond with Asp187 from another subu-
nit, while Arg129 could form salt bridge(s) with two neg-
atively charged candidates, Asp121 and Glu117. The
importance of these interactions was confirmed directly
with three mutations: His111Ala/Leu and Arg129Asp. The
His111Ala mutation resulted in dimers, while that of
His111Leu prevented the formation of an H-bond as well
as the formation of a dimer, most probably because of the
steric hindrance introduced by Leu (Figure 2). Substitu-
tion of Arg129 by Asp results in electrostatic repulsion
between the monomers, and simple calculations revealed
that the two abolished salt-bridges result in an approxi-
mately 1014-fold higher dimer dissociation constant (Kdd),
thus preventing dimerization. On the other hand, if all of
the binding energy were realized in the affinity change
caused by two H-bonds, as in the His111 mutants, only a
half of the above change would be expected. It appears
that this is still not enough to prevent dimerization (as
with His111Ala), unless the steric component is added (as
with His111Leu). Since both of the substituted residues
are the members of the αE helix, these results strongly sug-
gest that dimerization of fungal 17β-HSD takes place
across the Q-axis.
The denaturation of monomers occurs at higher 
temperatures
The results showed that the thermal denaturation of the
wild-type protein and the dimeric His111Ala mutant is a
cooperative process that involves the disruption of the
dimers and the denaturation of the monomers. Com-
pared with the wild-type protein, denaturation of this
mutant occurred at a lower temperature (Table 2). The
results indicated that the mutation introduced causes a
decrease in the thermal stability of the protein, and that
the His in position 111 is involved in interactions that sta-
bilize the dimer.
The higher melting temperature of the two monomeric
mutants, His111Leu and Arg129Asp, may be associated
with a higher stability of the monomers and with a
decreased flexibility of their structure in comparison with
the dimers. A higher flexibility may be needed to rear-
range the conformation after binding of the cofactor, thus
enabling proper binding of the substrate, and this may
also explain the loss of activity of the His111Leu and
Arg129Asp mutants. Additionally, the icebergs of solvent
(water) around the exposed hydrophobic groups of the αE
and αF helices may contribute to the higher Tm. As the
temperature is raised, the icebergs melt and their latent
heat of fusion contributes significantly to the specific heat
capacity (Cp) of the denatured state [29].
Dimerization is crucial for enzyme activity
The substitution of His111 by Ala at the Q-interface
resulted in higher Kd values and lower specificity constants
(kcat/KM) of this dimer when compared with the wild-type
enzyme, while the substitution of His111 by Leu and of
Arg129 by Asp resulted in inactive monomers. These
results indicate that H-bonds/salt bridges contribute to
both the specific dimerization and the enzyme activity.
The stability of the Q-interface, which is composed of the
αE and αF helices, is crucial for enzyme catalysis in the
SDR enzymes since two catalytic residues, Tyr(167) and
Lys(171), reside in the interior side of the αF helix, one
catalytic residue, Asn(127), resides in the interior side of
the αE helix, while Ser(153) is positioned in the small αEF
helix, between the βE strand and the αF helix [1,30]. The
proper orientation of these catalytically important helices
assures the proper orientation (setting, proximity, dis-
tance) of the catalytic amino acids to the nicotinamide
ring and the substrate, enabling the hydride transfer.
The investigation of another SDR member, glucose dehy-
drogenase (GlcDH) from Bacillus megaterium IWG3 (pdbBMC Biochemistry 2005, 6:28 http://www.biomedcentral.com/1471-2091/6/28
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code 1RWB) [31], supports our hypothesis. GlcDH func-
tions as a tetramer and its crystal structure has revealed
weaker hydrophobic interactions and a lack of salt bridges
in the Q-interface. For these reasons, the GlcDH tetramer
dissociates into inactive monomers at pH 9.0, but reversi-
bly associates into the fully active tetramer at pH 6.5. This
is not the case for our fungal enzyme, which is active in
the pH range of 7.0 to 9.0 [32]. Our results and those of
others have thus demonstrated that only upon dimeriza-
tion can the key catalytic residues be brought into the
positions that enable the substrate to be converted.
Since both of the mutant monomers show no enzymatic
activity despite their conserved secondary structures and
the positive coenzyme binding (Table 2), it appears that
the enzyme-coenzyme (E•NADP(H)) binary complex
undergoes conformational changes before the substrate
binding can occur. Such a conformational adaptation has
previously been proposed for 3α-HSD from the SDR
superfamily and for several members of the aldo-keto
reductase superfamily [33,34]. In these proteins, the bind-
ing of NADP(H) involves two events: an initial formation
of a loose complex (E•NADP(H)), followed by a confor-
mational change in the enzyme structure that leads to a
tightly bound complex (E*•NADP(H)) [33,34]. Our data
are in agreement with his hypothesis.
Dimerization via the Q-axis is not possible in 3α-HSD/CR, 
PTCR and CBR1
On comparing the crystal structures of dimeric and tetra-
meric SDRs with those of 3αHSD/CR, where dimerization
takes place via a P-axis interface [4,5], and of PTCR and
CBR1, the only monomeric enzyme structures of the SDR
superfamily [6,7], it becomes evident that in all three
structures, interactions across the Q-axis are blocked by
the presence of a predominantly α-helical subdomain. In
these three proteins, this 28, 41 or 41 amino-acid inser-
tion into the classical Rossman-fold motif between strand
βE and helix αF, respectively, prevents the formation of a
four-helix bundle, while at the same time it masks, and in
this manner stabilizes, the αE and αF helices. To deter-
mine whether the lack of this subdomain leads to the for-
mation of a homotetramer, a redesign of this interface was
recently performed in the dimeric 3α-HSD/CR, and fur-
ther enzymatic characterization is currently in progress
[34]. This insertion is not present in other SDRs that can
stabilize the αE and αF helices by dimerization via the Q-
axis interface. Therefore, again, dimerization appears to be
crucial for the stability of the αE and αF helices in the fun-
gal 17β-HSD as well as in other SDR proteins, except 3α-
HSD/CR, PTCR and CBR1.
Selective prevention of dimerization may enable the 
development of a new type of drug
A detailed understanding of the importance of specific res-
idues for dimerization should enable the design of com-
pounds that can prevent the dimerization and thus serve
as a new type of drug. This proposal is supported by the
finding that the residues involved in subunit interactions
differ considerably between the enzymes. Recently, Caf-
frey et al. (2004) examined the difference in conservation
between the protein-protein interfaces and the rest of the
protein surfaces for a set of 64 proteins from different pro-
tein superfamilies [36]. A surface-patch analysis showed
that this interface is rarely significantly more conserved
than other surface patches [36]. Although almost all of the
SDR proteins span across the Q-axis interface, the residues
involved in the dimerization are not conserved. Subunit
interactions at the αE-αE contact regions were compared
in 6 members of the SDR superfamily (GlcDH, mouse
lung carbonyl reductase, Streptomyces hydrogenans 3α,20β-
HSD,  Pseudomonas  sp.  cis-biphenyl-2,3-dihydrodiol-2,3-
dehydrogenase, Escherichia coli 7α-HSD, Magnaporthe gri-
sea  3HNR) [31], whereby different modes of subunit
interactions were shown in these proteins. Therefore, the
concept that the selective prevention of dimerization in
the SDR proteins will lead to the development of a new
type of inhibitors is reasonable.
Conclusion
Fungal 17β-HSD is a dimeric member of the SDR super-
family. We have shown by site-directed mutagenesis and
structure/function analysis that the dimerization takes
place across the Q-axis and involves the αE and αF helices
of both subunits. Neighbouring subunits are connected
through hydrophobic interactions, H-bonds and salt
bridges involving amino-acid residues His111 and
Arg129. The substitution of these amino acid residues
leads to inactive monomers with conserved secondary
structures that are still able to bind the coenzyme. Our
results indicate that the stability of the αE and αF helices
that include catalytic amino acid residues is crucial for
enzyme activity. Although oligomerization of the SDR
proteins has already been studied in Drosophila alcohol
dehydrogenase and human 17β-HSD type 1, our study is
the first that has prepared monomeric mutants in suffi-
cient quantities and qualities for structure/function analy-
sis.
Methods
Preparation of mutant proteins
The mutant proteins were prepared using the Quick-
Change Site-Directed Mutagenesis Kit (Stratagene) and
the pGex-17β-HSDcl expression vector [10]. The follow-
ing primers were used (only mutagenic forward primers
are shown; the mutations introduced are underlined):BMC Biochemistry 2005, 6:28 http://www.biomedcentral.com/1471-2091/6/28
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The fidelity of the constructs was confirmed by dideoxy
sequencing.
Expression and purification of proteins
All of the proteins were expressed as GST-fusion proteins
in the JM107 E. coli strain and purified by affinity chroma-
tography on Glutathione Sepharose followed by cleavage
with thrombin, as described previously [10].
SDS PAGE
Homogeneity of the proteins was checked by SDS-PAGE.
Samples (4 µg) were denatured in Laemmli sample buffer
(5 min at 90°C), applied to 12% acrylamide gels, and vis-
ualized by Coomassie Blue staining.
Estimations of molecular mass
Gel filtration
The molecular masses were determined by gel filtration
on BioCad Sprint FPLC. The mobile phase was 100 mM
phosphate buffer (Na2HPO4/NaH2PO4) with 150 mM
NaCl, pH 7.0. Approximately 40 µg of protein in 100 µl
was injected onto a TSK G4000 SWxl column (7.5 mm ID
× 60 cm) and analyzed at a 1.0 ml/min flow rate. Elution
of the proteins was followed at 280 nm. The void volume
of the column was determined with blue dextran. The cal-
ibration standards were: myoglobin (horse heart) (17.5
kDa), carbonic anhydrase (bovine erythrocyte) (29 kDa),
ovalbumin (albumin from hen egg white) (44 kDa), albu-
min (bovine serum) (66 kDa), alcohol deydrogenase
(yeast) (150 kDa), β-amylase (sweet potato) (200 kDa),
apoferritin (horse spleen) (443 kDa) and thyroglobulin
(bovine) (669 kDa).
Non-denaturing PAGE
Eight µg of protein were run on 9% acrylamide gels, as
described previously [37]. Following electrophoresis at
150 V, the proteins were stained by Coomassie Blue.
Secondary structure determinations
Preservation of the secondary structures was followed by
circular dichroism spectroscopy (JASCO Corp. J-715 spec-
tropolarimeter; PFD-350S temperature controller; main-
tained by J-700 software package). The spectra were
recorded at 20°C at 0.1 nm increments between 250 and
197 nm using 0.1 cm path length cuvettes. The scanning
speed was 50 nm/min, the response time 1 sec, and an
average of 4 scans was recorded. The protein concentra-
tions were approximately 0.2 mg/ml, in PBS (pH 7.3).
Thermal denaturation of proteins
Ellipticity was measured at 222 nm at 0.1°C increments
between 4 and 70°C. The temperature was raised at 30°C/
h, the response time was 16 sec, and the bandwidth was 1
nm. At the end of each experiment the temperature was
decreased to 4°C to verify the reversibility of the denatur-
ation.
Coenzyme binding
To determine coenzyme binding constants, we measured
the changes in the intrinsic enzyme fluorescence upon the
incremental addition of coenzymes (0–30 µM) on a Cary
Eclipse fluorescence spectrophotometer (Varian). To
ensure that the volume of coenzyme added was not more
than 3%, three stock solutions of the coenzyme were pre-
pared – 15 mM, 1.5 mM and 150 µM. A 4 × 10-mm
cuvette with a magnetic stirrer was used, and each 800 µl
sample contained 1 µM protein in 100 mM phosphate
buffer, pH 8.0 at 25°C. The samples were excitated at 290
nm with the fluorescence emission scanned at 335 nm
and with the excitation and emission band-passes set at 5
nm. Single or double hyperbolic equations were fitted to
the data to estimate the corresponding dissociation con-
stants for the wild-type and mutant forms of 17β-HSDcl.
Enzyme activities
The interconversion between 4-estrene-3,17-dione and 4-
estrene-17β-ol-3-one in the presence of NADPH or
NADP+ catalyzed by the wild-type and mutated enzymes
was followed photometrically at 340 nm, in 100 mM
phosphate buffer, pH 8.0 at 25°C. In all of the experi-
ments, 1% DMF was present, to enhance substrate solu-
bility. The time course of absorbance at 340 nm was
measured for 450 s. The progress curves were analyzed
according to the procedure described previously [38].
Thin-layer chromatography (TLC)
The wild-type and mutant proteins (0.5 µM) were incu-
bated with 4-estrene-17β-ol-3-one (100 µM) in the pres-
ence of NADP+ (500 µM) in 100 mM phosphate buffer,
pH 8.0, for 24 h at room temperature. The steroids were
extracted with chloroform and analyzed by TLC as
described previously [37].
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